Добірка наукової літератури з теми "Glioma patients"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Glioma patients".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Glioma patients"
Jiang, Chongming, Evelien Schaafsma, Yanding Zhao, Thinh Nguyen, Kenneth Zhu, and Chao Cheng. "Abstract LB528: A microglia associated gene signature predicts survival risk in glioma patients." Cancer Research 82, no. 12_Supplement (June 15, 2022): LB528. http://dx.doi.org/10.1158/1538-7445.am2022-lb528.
Повний текст джерелаZhao, Shiguang. "BIOM-63. DIAGNOSIS AND PROGNOSTIC SIGNIFICANCE OF CIRCULATING miR-2276-5p IN PLASMA OF GLIOMA PATIENTS." Neuro-Oncology 22, Supplement_2 (November 2020): ii15. http://dx.doi.org/10.1093/neuonc/noaa215.060.
Повний текст джерелаLi, shaoqun, Mingyao Lai, Jiangfen Zhou, junjie Zhen, and Linbo Cai. "PATH-22. GENETIC VARIATION BETWEEN IDH MUTANT AND IDH WILD-TYPE GLIOMA." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi119. http://dx.doi.org/10.1093/neuonc/noab196.474.
Повний текст джерелаPriambada, Dody, Muhamad Thohar Arifin, Surya Pratama Briliantika, Dian Widyaningrum, Abdi Saputro, Azka Tajussyarof El Muzakka, Yuriz Bakhtiar, Krisna Tsaniadi Prihastomo, and Zainal Muttaqin. "Serum GFAP and EGFR as Supportive Diagnostic Biomarker of Glioma Patients: A Single-Center Study." Open Access Macedonian Journal of Medical Sciences 10, B (April 20, 2022): 1093–96. http://dx.doi.org/10.3889/oamjms.2022.9021.
Повний текст джерелаKim, Junhyung, Min Woo Park, Young Joon Park, Ju Won Ahn, Jeong Min Sim, Suwan Kim, Jinhyung Heo, et al. "miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells." Genes 12, no. 5 (April 23, 2021): 633. http://dx.doi.org/10.3390/genes12050633.
Повний текст джерелаKim, Junhyung, Min Woo Park, Ju Won Ahn, Jeong Min Sim, Suwan Kim, Young Joon Park, Jinhyung Heo, et al. "TAMI-47. MIR-542-3P CONTRIBUTES TO THE HK2-MEDIATED HIGH GLYCOLYTIC PHENOTYPE IN HUMAN GLIOMA CELLS." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi208. http://dx.doi.org/10.1093/neuonc/noab196.830.
Повний текст джерелаTran Anh Duc, Nguyen Thanh Bac, Nguyen Van Ba, and Nguyen Duc Lien. "Study on some clinical features, histopathology and mutations in IDH, P53 genes, mgmt methylation in patients with high-grade glioma." VietNam Military Medical Unisversity 47, no. 6 (September 8, 2022): 191–99. http://dx.doi.org/10.56535/jmpm.v47i6.66.
Повний текст джерелаVattemi, Emanuela, Giovanna Cipollini, Cristina Dealis, Lorena Rossi, Susanne Baier, Elisabetta Cretella, Giovanni Di Meglio, et al. "Genetic polymorphisms of EGF 5'-UTR in patients with glioma: A possible predictive marker of outcome." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e13009-e13009. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13009.
Повний текст джерелаBracci, Paige, Terri Rice, Helen Hansen, Stephen Francis, Sean Lee, Lucie McCoy, Pavan Shrestha, et al. "EPID-08. PRE-SURGERY IMMUNE PROFILES OF ADULT GLIOMA PATIENTS." Neuro-Oncology 22, Supplement_2 (November 2020): ii79—ii80. http://dx.doi.org/10.1093/neuonc/noaa215.326.
Повний текст джерелаLi, D., Y. Chen, C. Guo, Q. Yang, S. Wu, Y. Xia, J. Zeng, et al. "P03.09 Real world management and prognosis of glioma patients:SYSUCC report from China." Neuro-Oncology 21, Supplement_3 (August 2019): iii26—iii27. http://dx.doi.org/10.1093/neuonc/noz126.090.
Повний текст джерелаДисертації з теми "Glioma patients"
Lilja, Åsa. "Psychoneurooncology psychological dynamics in glioma patients /." Lund : Dept. of Psychology, Lund University, 1992. http://books.google.com/books?id=SnZrAAAAMAAJ.
Повний текст джерелаLombardi, Giuseppe. "2-Hydroxyglutarate as a biomarker in glioma patients." Doctoral thesis, Università degli studi di Padova, 2014. http://hdl.handle.net/11577/3423791.
Повний текст джерелаBackground: la mutazione del gene IDH1 rappresenta un importante fattore prognostico e diagnostico per i tumori gliali. L’enzima IDH1 avente la mutazione ha la capacità di convertire α-KG in 2-Idrossiglutarato (2HG) e i gliomi mutati hanno una elevata concentrazione di 2HG all’interno delle cellule tumorali. Poichè 2HG è una piccola molecola, tale metabolita potrebbe raggiungere la circolazione sistemica ed essere escreta con le urine. Per tale ragione, nel nostro studio abbiamo analizzato la concentrazione di 2HG nel plasma e nelle urine nei pazienti con glioma per identificare un biomarcatore surrogato della presenza della mutazione IDH1. Materiali e Metodi: per l’arruolamento, tutti i pazienti dovevano avere avuto una precedente conferma istologica di glioma, una recente risonanza magnetica cerebrale (entro 2 settimane) mostrante la lesione tumorale. Qualsiasi chemioterapia eseguita nei 28 giorni precedenti l’analisi del metabolita, la presenza di altre malattie tumorali e malattie metaboliche escludevano l’arruolamento del paziente. Campioni plasmatici e urinari sono stati ottenuti da tutti i pazienti e le concentrazioni di 2HG ottenute mediante cromatografia liquida-spettrometria di massa; il test di Mann-Whitney è stato usato per calcolare le differenze di concentrazione dei metaboliti tra pazienti con IDH1 mutato e non-mutato, per dati non parametrici; il test di Student per comparare dati parametrici. La curva ROC è stata usata per calcolare il valore di cut-off del 2HG come biomarcatore. Risultati: sono stati arruolati 84 pazienti: 38 con IDH1 mutato e 46 con IDH1 wildtype. Tutte le mutazioni sono state R132H. Tra i pazienti con mutazione IDH1 abbiamo avuto 21 gliomi ad alto grado (HGG) e 17 gliomi a basso grado (LGG). Tra i pazienti con IDH1 wild-type abbiamo avuto 35 pazienti con HGG e 11 con LGG. In tutti i pazienti abbiamo analizzato la concentrazione media di 2HG nel plasma (P_2HG), nell’urina (U_2HG) e il rapporto tra la concentrazione plasmatica e urinaria (R_2HG). E’ emersa una importante differenza statisticamente significativa per l’R_2HG tra pazienti con e senza mutazione dell’IDH1 (22.2 verso 15.6, p<0.0001). Il cut-off ottimale di R_2HG per identificare lo stato mutazionale di IDH1 nei pazienti con glioma è risultato essere 19 (sensibilità 63%, specificità 76%, accuratezza 70%); nei soli pazienti con glioma ad alto grado il cut-off ottimale è risultato essere 20 (sensibilità 76%, specificità 89%, accuratezza 84%, valore predittivo positivo 80%, valore predittivo negativo 86%). Non è emersa nessuna associazione tra il grado o la dimensione del tumore con il valore di R_2HG. In 7 pazienti con glioma ad alto grado analizzati abbiamo, inoltre, trovato una correlazione tra il valore di R_2HG e la risposta al trattamento. Conclusioni: attraverso l’analisi di R_2HG, derivato dalla concentrazione plasmatica e urinaria di 2HG, è possibile discriminare gliomi con e senza mutazione IDH1, soprattutto in gliomi di alto grado. Occorrerà analizzare un campione più grande di pazienti con glioma per investigare tale metodica anche nel follow up allo scopo di individuare precocemente la recidiva di malattia e per monitorare l’efficacia del trattamento.
Dan, Michael. "Human anti-glioma monoclonal antibodies from patients with neurological tumors." Thesis, McGill University, 1989. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=74367.
Повний текст джерелаGittleman, Haley Rebecca. "Nomograms and Sex Differences in Survival for Patients with Glioma." Case Western Reserve University School of Graduate Studies / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=case1562341173580061.
Повний текст джерелаvan, Ierschot Fleur Céline. "Monitoring of reading and spelling in glioma patients undergoing awake surgery." Doctoral thesis, Università degli studi di Trento, 2018. https://hdl.handle.net/11572/367937.
Повний текст джерелаvan, Ierschot Fleur Céline. "Monitoring of reading and spelling in glioma patients undergoing awake surgery." Doctoral thesis, University of Trento, 2018. http://eprints-phd.biblio.unitn.it/2834/1/FvI_PhD_thesis.pdf.
Повний текст джерелаDavies, Elizabeth. "The quality of survival of patients with malignant cerebal glioma following radiotherapy." Thesis, Queen Mary, University of London, 1998. http://qmro.qmul.ac.uk/xmlui/handle/123456789/1664.
Повний текст джерелаChikada, Ai. "A descriptive analysis of end-of-life discussions for high-grade glioma patients." Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/264666.
Повний текст джерела新制・課程博士
博士(人間健康科学)
甲第23385号
人健博第92号
新制||人健||6(附属図書館)
京都大学大学院医学研究科人間健康科学系専攻
(主査)教授 田村 恵子, 教授 稲富 宏之, 教授 溝脇 尚志
学位規則第4条第1項該当
Doctor of Human Health Sciences
Kyoto University
DFAM
Cavers, Debbie Grant. "Understanding the supportive care needs of glioma patients and their relatives : a qualitative longitudinal study." Thesis, University of Edinburgh, 2010. http://hdl.handle.net/1842/10630.
Повний текст джерелаCoget, Arthur. "Etude et modélisation de la plasticité cérébrale chez des patients porteurs de lésions gliales de bas grade opérés en chirurgie éveillée." Thesis, Montpellier, 2020. http://www.theses.fr/2020MONTS053.
Повний текст джерелаIntroductionDiffuse low-grade gliomas (DLGG) are slow-growing brain tumors occurring in young adults. This slow progression induces extensive neuroplasticity and explains why patients most of the time do not show any obvious neurological deficit at the time of diagnosis although tumors are located in ‘eloquent’ areas. Therefore DLGG provide an interesting model in understanding mechanisms of neuroplasticity.Awake surgery with direct cortical and subcortical electrostimulation mapping is recommended as first-line treatment of DLGG, allowing to maximize tumoral resection and limiting postoperative neurological deficit, maintaining patients quality of life.Resting-state fMRI, based on BOLD signal analysis, is used to study functional connectivity and neural plasticity. This technique allows robust evaluation of neural networks without performing a task. Consequently, it bypasses the impact of confusion, sedation or neurological deficits on task execution. In this thesis, we aimed to investigate perioperative functional connectivity modifications in order to evaluate neural plasticity after awake surgery.Subsequently we explained the functional results using multimodal MRI imaging to analyze anatomic connectivity and hemodynamic parameters.Methods82 patients with DLGG who underwent awake surgical resection were included in the principal study. MRI acquisitions were performed successively before, within 36 h after and three months post-surgery. All scans were executed on the same MRI magnet for each patient, i.e. either a 3.0 T magnet (Skyra, Siemens) or a 1.5 T magnet (Avanto, Siemens). First, data were preprossed using a standardized classical pipeline and analyzed with the CONN toolbox v16.a.Second, anatomic connectivity was evaluated using diffusion tensor imaging of the corpus callosum.Finally hemodynamic changes induced by surgery were assessed with traditional perfusion imaging as well as using an innovative analysis of the BOLD signal’ s temporal shift.ResultsSurprisingly, it was found that specifically a diffuse transient postoperative interhemispheric disconnectivity occurred between homologous regions, known as homotopic connectivity.In parallel, immediate and long-term postoperative alterations in the anatomic connectivity of the corpus callosum were observed. Immediate and long-term postoperative modifications were also found regarding both regional and global hemodynamics characteristics. Yet, no significant link between the homotopic connectivity findings and the anatomical and hemodynamic changes could have been established at this point.Nevertheless, the hemodynamic analysis allowed the identification of a a specific brain region : the striatum. It was hypothesized that it acts as a central region for the maintenance of homotopic connectivity, explaining simultaneously the decreased post-surgical homotopic connectivity observed.ConclusionThe highlighted transient postoperative functional homotopy is probably due to multifactorial causes To start entangling these causes, the use of anatomic and hemodynamic imaging data analyses seems crucial to interpret functional connectivity data both immediate and long-term postoperative.Cerebral vasoreactivity and modelling studies provide thereby a very promising tool to better understand the interrelated processes underlying postoperative functional connectivity modifications
Книги з теми "Glioma patients"
Elizabeth, Davies, and Hopkins Anthony, eds. Improving care for patients with malignant cerebral glioma. London: Royal College of Physicians, 1997.
Знайти повний текст джерелаBinding distribution and cellular uptake of Na2B12H11SH (BSH) in tumor tissue of glioma patients: Investigations for boron neutron capture therapy. Aachen: Shaker, 1997.
Знайти повний текст джерелаGuerrero, Douglas. A retrospective analysis investigating the prevalence of epilepsy in patients with gliomas. [Guildford]: [University of Surrey], 1994.
Знайти повний текст джерела(Editor), Elizabeth Davies, and Anthony Hopkins (Editor), eds. Improving Care for Patients with Malignant Cerebral Glioma. Royal College of Physicians of London, 1997.
Знайти повний текст джерелаSanai, Nader. Low-Grade Gliomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0027.
Повний текст джерелаKaley, Thomas J. Oligodendrogliomas. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0128.
Повний текст джерелаWeller, Michael, Michael Brada, Tai-Tong Wong, and Michael A. Vogelbaum. Astrocytic tumours: diffuse astrocytoma, anaplastic astrocytoma, glioblastoma, and gliomatosis cerebri. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199651870.003.0003.
Повний текст джерелаHuntoon, Kristin, and J. Bradley Elder. High-Grade Gliomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0001.
Повний текст джерелаTaillandier, Luc, Laurent Capelle, and Hugues Duffau. New Therapeutic Strategies in Low-grade Gliomas. Nova Science Publishers, 2006.
Знайти повний текст джерелаEseonu, Chikezie I., Jordina Rincon-Torroella, and Alfredo Quiñones-Hinojosa. Unusual Gliomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0002.
Повний текст джерелаЧастини книг з теми "Glioma patients"
Fujiwara, S. "Clinical Study Using MRI in Patients Treated with RAFP Therapy." In Treatment of Glioma, 231–40. Tokyo: Springer Japan, 1988. http://dx.doi.org/10.1007/978-4-431-68453-4_15.
Повний текст джерелаMori, T. "The Pharmacokinetics of ACNU in Patients with Malignant Brain Tumor." In Treatment of Glioma, 109–16. Tokyo: Springer Japan, 1988. http://dx.doi.org/10.1007/978-4-431-68453-4_4.
Повний текст джерелаPuumalainen, Anu-Maaria, Matti Vapalahti, and Seppo Ylä-Herttuala. "Gene Therapy for Malignant Glioma Patients." In Advances in Experimental Medicine and Biology, 505–9. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5357-1_78.
Повний текст джерелаFankhauser, Heinz, Giuseppe Stragliotto, and Pascal Zbinden. "Borocaptate Sodium (BSH) Pharmacokinetics in Glioma Patients." In Boron Neutron Capture Therapy, 155–62. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_17.
Повний текст джерелаSmits, Anja, and Anette Storstein. "Tumor-Associated Epilepsy in Patients with Glioma." In Tumors of the Central Nervous System, Volume 2, 397–406. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-0618-7_39.
Повний текст джерелаWalbert, Tobias, and Kristen Chasteen. "Palliative and Supportive Care for Glioma Patients." In Cancer Treatment and Research, 171–84. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12048-5_11.
Повний текст джерелаHam, Timothy, and Timothy Rittman. "Neurological Assessment of Patients with Gliomas." In Management of Adult Glioma in Nursing Practice, 37–48. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-76747-5_3.
Повний текст джерелаHerold-Mende, Christel, and Benito Campos. "Glioma Patients: Role of CD133 Stem Cell Antigen." In Stem Cells and Cancer Stem Cells, Volume 1, 69–76. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-1709-1_8.
Повний текст джерелаKaprelyan, A. G., N. M. Mincheva, K. T. Metodiev, D. M. Minchev, and D. S. Cholakov. "Immunologic Monitoring in Patients with Glioma Treated Neurosurgically." In Immunology and Its Impact on Infections in Surgery, 196–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79079-9_28.
Повний текст джерелаMaeda, Tatsuhiro, Kazuhiko Saruta, Satoyuki Ito, Hiroki Sawa, and Isamu Saito. "Efficiency of Glioma Score in Glioma Patients Using Proliferating Potential with MIB-1 Monoclonal Antibody." In Brain Tumor, 141–48. Tokyo: Springer Japan, 1996. http://dx.doi.org/10.1007/978-4-431-66887-9_15.
Повний текст джерелаТези доповідей конференцій з теми "Glioma patients"
Hayashi, Shigeto, Atsushi Sakuma, Takashi Sasayama, and Eiji Kohmura. "Measurement of Glioma Viscoelasticity Using a Handheld Palpation Imitation Device." In ASME 2017 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/imece2017-70835.
Повний текст джерелаBen Abdallah, Meriem, Marie Blonski, Sophie Wantz-Mezieres, Yann Gaudeau, Luc Taillandier, and Jean-Marie Moureaux. "Predictive models for diffuse low-grade glioma patients under chemotherapy." In 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2016. http://dx.doi.org/10.1109/embc.2016.7591692.
Повний текст джерелаWijethilake, Navodini, Dulani Meedeniya, Charith Chitraranjan, and Indika Perera. "Survival prediction and risk estimation of Glioma patients using mRNA expressions." In 2020 IEEE 20th International Conference on Bioinformatics and Bioengineering (BIBE). IEEE, 2020. http://dx.doi.org/10.1109/bibe50027.2020.00014.
Повний текст джерелаPapp, L., S. Rasul, M. Weber, M. Grahovac, T. Beyer, M. Hacker, and T. Traub-Weidinger. "Understanding gender pattern differences in MET-PET Glioma patients with radiomics analysis." In NuklearMedizin 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1708295.
Повний текст джерелаBoisselier, Blandine, Marianne Labussiere, Marta Rossetto, Jaime Gallego Perez Larraya, Yannick Marie, Jean-Yves Delattre, and Marc Sanson. "Abstract 5559: Detection of IDH1 mutation in the plasma of glioma patients." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5559.
Повний текст джерелаVoigt, Tobias. "Imaging conductivity using electric properties tomography — Initial clinical results in glioma patients." In 2011 XXXth URSI General Assembly and Scientific Symposium. IEEE, 2011. http://dx.doi.org/10.1109/ursigass.2011.6051346.
Повний текст джерелаPescatello, Meredith, Nimish Mohile, Jennifer Serventi, Bethann Sayers, Jacqueline Behr, Lauryn Hemminger, and Sara Hardy. "Structured Early Advanced Care Planning Outcomes for Patients with High Grade Glioma (S17.006)." In 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000203293.
Повний текст джерелаSharma, Puja, Brian Koons, and Amrinder S. Nain. "Blebbing Dynamics, Single Cell Force Measurements, and the Influence of Cytochalasin D on Glioblastoma Multiforme Cells Using STEP Fibers." In ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/nemb2013-93105.
Повний текст джерелаrathore, saima, Spyridon Bakas, Hamed Akbari, MacLean P. Nasrallah, Stephen Bagley, and Christos Davatzikos. "Abstract 1392: Machine Learning Radiomic Biomarkers Non-invasively Assess Genetic Characteristics of Glioma Patients." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-1392.
Повний текст джерелаrathore, saima, Spyridon Bakas, Hamed Akbari, MacLean P. Nasrallah, Stephen Bagley, and Christos Davatzikos. "Abstract 1392: Machine Learning Radiomic Biomarkers Non-invasively Assess Genetic Characteristics of Glioma Patients." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1392.
Повний текст джерелаЗвіти організацій з теми "Glioma patients"
Yang, Chao, Tao-junjin Lu, Jie Wang, Qing Zhang, Ze-Fen Wang, and Zhi-Qiang Li. Association of systemic immune-inflammation index with grade and prognosis in glioma patients: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0072.
Повний текст джерелаYin, Liangyu, Feifei Chong, Zhenyu Huo, Na Li, Jie Liu, and Hongxia Xu. GLIM-defined malnutrition and overall survival in cancer patients: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0113.
Повний текст джерела